LCM
FULC icon

Landscape Capital Management’s Fulcrum Therapeutics FULC Stock Holding History

Landscape Capital Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,489
Closed -$65K – 747
2024
Q2 		$65K Sell
10,489
-84,286
-89% -$638K 0.01% 653
2024
Q1 		$895K Buy
94,775
+30,021
+46% +$268K 0.08% 321
2023
Q4 		$437K Buy
64,754
+36,502
+129% +$162K 0.04% 456
2023
Q3 		$125K Buy
+28,252
New +$123K 0.02% 417
2023
Q2 		– Sell
-13,740
Closed -$39.2K – 626
2023
Q1 		$39.2K Buy
13,740
+2,626
+24% +$23.5K 0.01% 573
2022
Q4 		$80.9K Buy
+11,114
New +$72.5K 0.01% 761

Other funds holding FULC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Landscape Capital Management's FULC Position: Q3 2024 in Review

Landscape Capital Management sold out of Fulcrum Therapeutics (FULC) in Q3 2024, closing a stake of 10,489 shares — an estimated $65K sold.

Landscape Capital Management first reported a position in FULC in Q4 2022 and held it in 6 quarters. The position peaked at $895K in Q1 2024. 130 funds tracked by Wall St. Rank hold FULC as of Q3 2024.

  • Landscape Capital Management reported no remaining Fulcrum Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Landscape Capital Management sold 10,489 Fulcrum Therapeutics shares in Q3 2024, an estimated $65K.
  • Landscape Capital Management first reported a position in Fulcrum Therapeutics in Q4 2022 and held it in 6 quarters.
  • Landscape Capital Management's Fulcrum Therapeutics position peaked at $895K in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2024.

Based on Landscape Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.